Jun Gui

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Etoposide activates CD8+ T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling.

Etoposide activates CD8+ T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2025

Cancer Stem Cells Shift Metabolite Acetyl-Coenzyme A to Abrogate the Differentiation of CD103+ T Cells.

Cancer Stem Cells Shift Metabolite Acetyl-Coenzyme A to Abrogate the Differentiation of CD103+ T Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 18, 2025

Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis.

Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis.

Journal: Cell reports

Published: April 21, 2025

In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes.

In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes.

Journal: Cancer immunology research

Published: August 28, 2024

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells.

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells.

Journal: Cell metabolism

Published: March 27, 2024

Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders.

Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 19, 2024

A Single-Atom Manganese Nanozyme Mn-N/C Promotes Anti-Tumor Immune Response via Eliciting Type I Interferon Signaling.

A Single-Atom Manganese Nanozyme Mn-N/C Promotes Anti-Tumor Immune Response via Eliciting Type I Interferon Signaling.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 23, 2023

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells.

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells.

Journal: Cell metabolism

Published: July 07, 2023

Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer.

Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer.

Journal: Cell death & disease

Published: July 03, 2023

Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity.

Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity.

Journal: Cancer letters

Published: June 14, 2023

Editorial: Viral infection, tumor development and host immune response.

Editorial: Viral infection, tumor development and host immune response.

Journal: Frontiers in cellular and infection microbiology

Published: March 01, 2023

Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.

Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.

Journal: Cancer immunology research

Published: April 15, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026